Free Trial

ICU Medical, Inc. (NASDAQ:ICUI) Shares Bought by Dimensional Fund Advisors LP

ICU Medical logo with Medical background

Dimensional Fund Advisors LP lifted its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 18.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 539,981 shares of the medical instruments supplier's stock after purchasing an additional 82,982 shares during the quarter. Dimensional Fund Advisors LP owned about 2.21% of ICU Medical worth $83,788,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. CANADA LIFE ASSURANCE Co increased its position in shares of ICU Medical by 0.7% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 28,476 shares of the medical instruments supplier's stock valued at $4,412,000 after acquiring an additional 188 shares during the period. Gabelli Funds LLC increased its holdings in ICU Medical by 1.4% in the fourth quarter. Gabelli Funds LLC now owns 70,500 shares of the medical instruments supplier's stock valued at $10,939,000 after buying an additional 950 shares in the last quarter. Mariner LLC increased its holdings in ICU Medical by 24.4% in the 4th quarter. Mariner LLC now owns 5,009 shares of the medical instruments supplier's stock worth $777,000 after acquiring an additional 984 shares in the last quarter. Sterling Capital Management LLC lifted its holdings in ICU Medical by 813.5% during the fourth quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock valued at $105,000 after purchasing an additional 602 shares in the last quarter. Finally, CenterBook Partners LP acquired a new position in shares of ICU Medical during the 4th quarter worth about $1,467,000. Hedge funds and other institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on ICUI. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Raymond James set a $97.00 price target on ICU Medical in a research note on Wednesday, March 12th. KeyCorp cut their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $162.67.

View Our Latest Stock Report on ICUI

ICU Medical Trading Up 3.4 %

Shares of NASDAQ ICUI traded up $4.67 during trading on Friday, reaching $141.64. The stock had a trading volume of 174,792 shares, compared to its average volume of 274,714. The company has a market cap of $3.49 billion, a P/E ratio of -30.99 and a beta of 0.86. ICU Medical, Inc. has a fifty-two week low of $96.97 and a fifty-two week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The business's 50-day moving average price is $141.61 and its 200-day moving average price is $156.60.

ICU Medical Company Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Featured Articles

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Should You Invest $1,000 in ICU Medical Right Now?

Before you consider ICU Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.

While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines